RE: RE: Dissident FUEL - revised....... Somewey. Have a look at your list, and tell me any other word to describe the Captain of that ship. Seriously give me three other adjectives to describe him. Sure Graeme has a great mind when it comes to obtaining valuable assets, but when it comes to monetizing them, he has been an abject failure. I still think we are all going to make a lot of money, but it will be in spite of Graeme, not because of him.
I will add to your list:
** over promising, missing deadlines, stubborn refusal to move into the 21st century in their on line presence, small thinking...
a Sunday evening 15% loan release followed by detailed explanations from regular board bashers
* Monday morning NR's at the beginning of tax loss season that makes you wonder why BNC even made the announcement
* NR's at 6pm on Friday night 3 days before Cristmas that scare the daylights out of uninformed shareholders
* positive NR's involving US partners that are released at 5:30pm on US Thanksgiving Eve
* websites that share similar info available 2 weeks prior
* Halts with the stock flying that last all day and end up saying nothing
* purchases with 15 minutes left in trading that move the stock from .72 to .90 so that it can trade at .60 the next morning
* .35 option grants in the face of a completely embarrassing performance by the company
* An Australian Exchange that has virtually No volume except for the transfer of shares across exchanges
* a BNN visit where the BNC rep fails to offer a ticker symbol or any mention of where we trade
* the largest ecoli crisis in Canadian history that sees ZERO appreciation for a company with a solution
* DITTO a year prior for a similar crisis in Europe
* failure to let shareholders know we've hired an IR firm to help create awareness
* a wonderful glossy marketing piece for Australia, but only select Canadian exposure
* participation in a San Fran bio-tech event that is only brought to our attention thanks to a motorcycle
* news on the Belgrade Cevapi-fest and silence on wonderful results with partner Bayer
* paid for IR that has a $1 target while Canada and Australia call for $3